4.8 Editorial Material

Response under pressure: deploying emerging technologies to understand B-cell-mediated immunity in COVID-19

Journal

NATURE METHODS
Volume 19, Issue 4, Pages 387-391

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41592-022-01450-1

Keywords

-

Funding

  1. National Institutes of Health [UL TR000424, U54-CA260563-01, P01-AI125180-01, R37-AI049660, 1R01AI12125, 1U01AI141993]
  2. National Institutes of Health: Emory Autoimmunity Center of Excellence [U19-AI110483]
  3. Bill and Melinda Gates Foundation [INV-002351]
  4. Bill and Melinda Gates Foundation [INV-002351] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

This article discusses the critical technological advances in rapidly investigating the immune responses triggered by the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic. It focuses on state-of-the-art methods used to analyze B-cell responses against the virus and their impact on the ongoing public health crisis.
Critical technological advances have enabled the rapid investigations into the immune responses elicited by SARS-CoV-2, the pathogen responsible for the COVID-19 pandemic. We discuss the cutting-edge methods used to deconvolve the B-cell responses against this virus and the impact they have had in the ongoing public health crisis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available